MAGELLAN HEALTH, INC. MGLN Cash Flow

Magellan health, inc. (MGLN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities:
Net income
73,721	55,902	7,351	13,222	13,160	24,181	106,657	112,748	104,124	110,141	91,409	83,482	79,867	75,789	64,993	31,923	34,904	28,707	23,472	57,011	57,045	74,231	72,976	94,430	121,583	125,261	143,772	162,802	158,295	151,027	143,764	108,857	116,115	129,623	132,812	146,241	147,438	138,659	0	0	0
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization
129,485	131,509	133,713	132,603	132,961	132,660	130,112	125,254	119,137	115,706	111,470	110,166	108,015	106,046	105,077	104,913	104,355	102,844	99,644	96,879	94,337	91,070	87,889	81,587	76,053	71,994	66,086	63,671	61,877	60,488	60,507	60,337	59,452	58,623	56,363	55,244	55,212	54,682	0	0	0
Non-cash interest expense
1,796	1,537	1,371	1,286	1,240	1,221	2,556	4,793	4,811	4,757	3,300	939	716	565	487	406	402	399	396	2,612	3,902	3,987	4,072	1,940	736	736	736	736	735	728	1,257	1,180	1,103	1,033	426	421	457	569	0	0	0
Non-cash stock compensation expense
21,951	25,501	21,899	26,408	31,433	29,472	34,687	35,690	36,622	39,116	41,683	40,536	38,675	37,422	37,364	41,085	45,370	50,384	55,194	54,258	50,013	40,584	32,471	25,034	20,086	21,252	18,612	18,556	18,319	17,783	17,945	17,902	17,742	17,418	16,680	15,851	15,352	15,102	0	0	0
Non-cash income tax (benefit) provision
15,104	7,052	1,028	-599	-2,037	-1,725	-27,007	-29,561	-29,909	-30,981	-448	1,620	4,238	4,710	-22,983	-22,106	-25,274	-26,999	-6,122	-6,056	-2,821	-4,291	-235	-4,105	-4,315	-1,212	4,747	11,735	13,980	17,306	13,421	8,306	11,453	8,285	17,250	31,097	33,899	42,251	0	0	0
Non-cash amortization on investments
-84	433	569	154	-343	-1,344	-2,276	-3,001	-3,621	-3,924	-4,066	-4,185	-4,506	-5,238	-6,236	-7,299	-7,423	-7,118	-6,536	-5,363	-4,978	-5,050	-5,454	-6,876	-8,210	-9,107	-9,093	-8,357	-7,941	-7,193	-8,022	-9,381	-10,841	-12,309	0	0	0	-	-	-	-
Changes in assets and liabilities, net of effects from acquisitions of businesses:
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-51,301	-30,055	34,876	2,242	-37,004	-19,171	36,848	40,760	90,012	105,602	83,831	69,060	58,313	-20,666	-20,340	-42,925	0	0	0
Accounts receivable, net
143,486	133,999	-7,348	-28,511	35,921	99,295	188,275	198,401	100,389	40,910	115,702	81,518	148,250	134,089	42,892	94,760	67,357	52,394	96,540	90,916	108,022	74,604	41,065	29,195	-2,398	40,804	36,246	45,200	12,664	16,411	6,566	-62,850	21,571	15,609	15,456	71,324	2,118	-3,262	0	0	0
Pharmaceutical inventory
-4,818	4,144	4,338	-4,722	9,273	-127	-4,906	-9,405	-24,051	-17,605	-11,788	-2,812	6,504	8,246	16,522	20,701	21,265	11,374	3,753	-1,983	-12,500	-10,234	-6,508	-5,600	-626	3,882	5,838	11,523	4,662	6,160	9,962	-6,673	-2,719	11,657	0	0	0	-	-	-	-
Other assets
11,535	-19,492	1,480	-7,734	-1,305	25,774	49,092	39,989	41,307	4,565	-42,993	-20,586	-20,767	13,900	19,572	20,760	4,471	-4,149	33,832	11,433	17,503	7,557	21,890	28,687	24,527	9,293	5,149	3,560	7,693	-414	3,094	-3,521	4,576	-3,804	8,082	24,545	4,616	14,847	0	0	0
Accounts payable and accrued liabilities
89,190	56,843	106,896	-20,362	3,009	9,139	-28,220	25,249	-5,078	-84,445	-41,406	-21,424	-11,774	52,470	33,862	50,918	1,250	-36,043	-11,687	-61,118	-50,344	5,887	-31,553	27,802	49,222	3,593	16,218	-17,942	3,118	-8,321	-14,889	-175	-8,183	-7,251	3,342	12,399	10,216	14,447	0	0	0
Medical claims payable and other medical liabilities
-62,262	-28,969	10,677	-13,256	-15,551	72,347	74,324	110,189	138,964	26,235	35,553	32,396	25,090	-8,042	-41,649	-43,817	-25,768	36,187	75,549	82,557	69,530	55,670	41,662	30,139	11,917	17,866	10,014	17,468	27,843	31,292	44,980	24,693	21,418	-7,905	2,260	-1,114	6,913	3,638	0	0	0
Contingent consideration
-	-3,877	-2,898	-2,754	-535	1,307	1,778	796	978	696	-1,245	-98	-51,988	-51,205	-54,779	-32,114	40,800	55,035	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax contingencies
-510	-1,352	1,452	1,692	1,438	1,803	1,623	1,638	1,623	1,681	942	790	890	673	1,158	204	55	-1,021	-2,066	-16,697	-16,543	-14,955	-15,158	-23,145	-22,760	-22,960	-23,741	-35,505	-35,465	-35,376	0	0	0	-	-	-	-	-	-	-	-
Deferred credits and other long-term liabilities
-4,776	-10,668	-8,043	-6,293	-2,554	18,020	17,307	18,220	16,753	3,218	2,217	-4,365	-1,207	-5,584	-3,989	2,016	547	294	-1,005	-380	1,032	4,045	12,707	13,981	13,299	10,988	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Other
-836	-1,452	-843	-320	-218	-17	22	-528	-426	-95	-319	335	403	-52	-140	-242	-208	-171	-118	-369	-320	-322	-982	-991	-2,457	-2,757	-1,488	-2,130	-704	-189	2,562	2,583	3,173	-285	-3,820	1,411	-1,686	-445	0	0	0
Net cash provided by operating activities
112,148	115,846	275,250	173,080	119,236	164,844	83,610	179,560	274,427	162,273	186,939	189,772	67,438	66,699	-28,228	-74,456	81,440	157,457	173,556	165,298	151,002	189,673	206,121	233,303	220,109	183,161	240,918	193,170	197,603	181,293	127,541	188,923	112,304	112,003	150,781	180,864	277,937	308,941	0	0	0
Cash flows from investing activities:
Capital expenditures
63,479	60,402	61,265	58,947	61,415	68,275	65,773	67,567	65,795	57,232	59,239	57,156	56,209	60,881	61,325	64,453	65,799	71,584	66,344	67,983	72,674	62,337	73,048	69,514	64,219	64,542	58,591	59,707	66,426	69,549	68,975	64,578	58,809	54,394	52,429	51,174	46,247	46,162	0	0	0
Acquisitions and investments in businesses, net of cash acquired
776	727	0	0	0	-	-	-	-	232,403	75,506	186,960	183,796	199,237	126,931	15,352	57,819	55,818	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	376	0	0	0	-	-	-	-
Purchases of investments
505,869	514,324	495,287	518,750	587,112	557,232	561,600	545,309	451,327	449,873	454,236	506,230	462,889	478,477	443,829	387,806	498,262	470,093	515,788	522,221	393,264	340,961	304,265	269,969	333,205	323,253	359,962	343,758	326,160	321,541	246,187	214,900	141,757	259,552	266,759	382,581	440,119	291,289	0	0	0
Proceeds from maturities and sales of investments
579,606	555,960	531,842	558,876	507,781	498,032	503,756	417,421	410,277	423,118	440,607	480,613	481,194	494,256	494,383	435,110	456,711	404,308	339,874	345,898	294,521	276,446	325,896	346,892	366,205	339,428	300,321	269,926	232,227	281,748	314,640	358,430	354,736	330,583	303,071	265,041	262,937	226,957	0	0	0
Net cash used in investing activities
9,482	-19,493	-25,586	-20,099	-142,024	-128,433	-353,222	-424,658	-339,048	-316,390	-148,374	-269,733	-221,700	-244,339	-137,702	-32,501	-165,169	-193,187	-294,143	-303,531	-313,334	-255,129	-283,268	-217,227	-138,760	-155,908	-127,357	-142,664	-161,584	-110,567	-522	78,850	154,068	16,261	-16,493	-168,988	-223,703	-110,494	0	0	0
Cash flows from financing activities:
Proceeds from borrowings on revolving line of credit
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of debt
-	-	-	-	-	-	-	-	-	1,041,736	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments to acquire treasury stock
-	4,125	0	0	0	-	-	-	-	-	-	-	-	106,806	162,087	162,719	181,924	206,044	208,980	201,062	212,675	197,533	150,531	76,469	52,817	60,677	0	0	0	-	-	-	-	407,645	403,264	286,829	212,597	149,805	0	0	0
Proceeds from exercise of stock options
41,566	32,708	21,130	22,235	8,212	23,064	38,614	59,885	56,307	44,355	42,540	21,400	22,306	25,145	14,352	14,014	24,377	53,493	61,383	67,967	82,714	52,994	64,666	65,616	45,034	47,529	31,942	33,593	27,964	20,486	20,133	15,957	35,977	41,796	104,510	104,570	86,382	92,876	0	0	0
Payments on debt, finance lease and deferred financing obligations
94,962	67,511	98,146	103,870	73,667	122,239	80,077	646,327	676,550	803,393	805,681	202,468	199,475	20,891	17,942	18,140	17,530	17,038	18,104	14,257	10,590	8,045	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1,120	0	0	0
Payments on contingent consideration
-	6,247	0	0	0	-	-	-	-	-	-	-	-	40,559	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefit from exercise of stock options and vesting of stock awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,073	4,300	4,608	5,662	3,218	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Other
2,329	1,763	1,763	1,585	329	-1,020	-2,575	-11,300	-11,336	-9,560	-8,049	13	27	1,230	1,275	931	1,144	409	-1,875	-3,906	-4,099	-4,433	-3,227	-989	-712	-593	-383	-744	-1,011	-732	-1,915	-2,337	-1,391	-1,211	1,603	1,048	-79	-847	0	0	0
Proceeds from issuance of equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20,000	0	0	0	-	-	-	-
Net cash (used in) provided by financing activities
28,932	-43,412	-107,225	-138,738	-138,137	-162,835	-888	209,874	185,360	248,341	246,560	81,996	260,485	233,119	73,395	3,104	-195,583	-185,869	-172,208	98,911	111,012	96,201	163,628	-9,518	-8,470	-13,530	-41,091	-39,307	-19,169	-1,124	-60,062	-181,095	-249,509	-345,581	-276,562	-160,622	-105,794	-57,775	0	0	0
Net (decrease) increase in cash and cash equivalents
150,562	52,941	142,439	14,243	-160,925	-126,424	-270,500	-35,224	120,739	94,224	285,125	2,035	106,223	55,479	-92,535	-103,853	-279,312	-221,599	-292,795	-39,322	-51,320	30,745	86,481	6,558	72,879	13,723	72,470	11,199	16,850	69,602	66,957	86,678	16,863	-217,317	-142,274	-148,746	-51,560	140,672	0	0	0
Supplemental Cash Flow Information [Abstract]
Non-cash investing activities:
Assets acquired under finance leases and deferred financing obligations
3,599	3,302	4,333	19,255	23,827	20,576	19,545	4,623	1,563	2,418	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-